BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26606447)

  • 1. DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding.
    Li CM; Zheng LL; Yang XX; Wan XY; Wu WB; Zhen SJ; Li YF; Luo LF; Huang CZ
    Biomaterials; 2016 Jan; 77():216-26. PubMed ID: 26606447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
    Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses.
    Yuan L; Zhang S; Wang Y; Li Y; Wang X; Yang Q
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30068648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water extract of Cinnamomum cassia Blume inhibited human respiratory syncytial virus by preventing viral attachment, internalization, and syncytium formation.
    Yeh CF; Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):321-6. PubMed ID: 23518419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of DNA-AuNP networks on cell membranes and real-time movies for viral infection.
    Li C; Zheng L; Yang X; Wan X; Wu W; Zhen S; Li Y; Luo L; Huang C
    Data Brief; 2016 Mar; 6():652-60. PubMed ID: 26909382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
    Chang JS; Wang KC; Shieh DE; Hsu FF; Chiang LC
    J Ethnopharmacol; 2012 Jan; 139(1):305-10. PubMed ID: 22120014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.
    Vigant F; Lee J; Hollmann A; Tanner LB; Akyol Ataman Z; Yun T; Shui G; Aguilar HC; Zhang D; Meriwether D; Roman-Sosa G; Robinson LR; Juelich TL; Buczkowski H; Chou S; Castanho MA; Wolf MC; Smith JK; Banyard A; Kielian M; Reddy S; Wenk MR; Selke M; Santos NC; Freiberg AN; Jung ME; Lee B
    PLoS Pathog; 2013; 9(4):e1003297. PubMed ID: 23637597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.
    Chang JS; Yeh CF; Wang KC; Shieh DE; Yen MH; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):481-7. PubMed ID: 23542148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.
    Cagno V; Donalisio M; Civra A; Volante M; Veccelli E; Oreste P; Rusnati M; Lembo D
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4782-94. PubMed ID: 24914125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The compound DATEM inhibits respiratory syncytial virus fusion activity with epithelial cells.
    Ohki S; Liu JZ; Schaller J; Welliver RC
    Antiviral Res; 2003 Apr; 58(2):115-24. PubMed ID: 12742571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A generic screening platform for inhibitors of virus induced cell fusion using cellular electrical impedance.
    Watterson D; Robinson J; Chappell KJ; Butler MS; Edwards DJ; Fry SR; Bermingham IM; Cooper MA; Young PR
    Sci Rep; 2016 Mar; 6():22791. PubMed ID: 26976324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments.
    Varghese FS; Rausalu K; Hakanen M; Saul S; Kümmerer BM; Susi P; Merits A; Ahola T
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effect of 25-hydroxycholesterol against porcine reproductive and respiratory syndrome virus in vitro.
    Dong H; Zhou L; Ge X; Guo X; Han J; Yang H
    Antivir Ther; 2018; 23(5):395-404. PubMed ID: 29561734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
    Schepens B; Ibañez LI; De Baets S; Hultberg A; Bogaert P; De Bleser P; Vervalle F; Verrips T; Melero J; Vandevelde W; Vanlandschoot P; Saelens X
    J Infect Dis; 2011 Dec; 204(11):1692-701. PubMed ID: 21998474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.
    Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R
    J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
    Yan D; Weisshaar M; Lamb K; Chung HK; Lin MZ; Plemper RK
    Biochemistry; 2015 Sep; 54(36):5589-604. PubMed ID: 26307636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication.
    Yen MH; Lee JJ; Yeh CF; Wang KC; Chiang YW; Chiang LC; Chang JS
    J Ethnopharmacol; 2014 Feb; 151(3):1056-1063. PubMed ID: 24361333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.